HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monika Kubacka Selected Research

MH-76 compound

11/2023Manifestations of Liver Impairment and the Effects of MH-76, a Non-Quinazoline α1-Adrenoceptor Antagonist, and Prazosin on Liver Tissue in Fructose-Induced Metabolic Syndrome.
5/2021MH-76, a Novel Non-Quinazoline α1-Adrenoceptor Antagonist, but Not Prazosin Reduces Inflammation and Improves Insulin Signaling in Adipose Tissue of Fructose-Fed Rats.
1/2019Beneficial effects of non-quinazoline α1-adrenolytics on hypertension and altered metabolism in fructose-fed rats. A comparison with prazosin.
1/2019Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Monika Kubacka Research Topics

Disease

4Pain (Aches)
05/2024 - 06/2015
4Hypertension (High Blood Pressure)
11/2023 - 01/2019
4Inflammation (Inflammations)
08/2023 - 06/2015
3Insulin Resistance
11/2023 - 01/2019
3Seizures (Absence Seizure)
06/2021 - 11/2006
3Cardiac Arrhythmias (Arrythmia)
07/2014 - 02/2008
2Peripheral Nervous System Diseases (PNS Diseases)
05/2024 - 11/2020
2Alzheimer Disease (Alzheimer's Disease)
11/2023 - 11/2023
2Psychotic Disorders (Schizoaffective Disorder)
11/2023 - 03/2022
2Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2023 - 01/2019
2Myocardial Infarction
11/2023 - 05/2021
2Neuralgia (Stump Neuralgia)
02/2023 - 11/2020
2Obesity
06/2022 - 03/2021
2Hypertrophy
06/2022 - 01/2019
2Peritonitis
01/2017 - 06/2015
2Edema (Dropsy)
01/2017 - 06/2015
2Hyperalgesia
01/2017 - 06/2015
1Non-alcoholic Fatty Liver Disease
02/2024
1Fatty Liver
11/2023
1Hepatocellular Carcinoma (Hepatoma)
11/2023
1Pruritus (Itching)
10/2023
1Infarction (Infarctions)
08/2023
1Stroke (Strokes)
08/2023
1Atherosclerosis
08/2023
1Weight Gain
06/2022
1Mental Disorders (Mental Disorder)
03/2022
1Schizophrenia (Dementia Praecox)
03/2022
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Acute Coronary Syndrome
10/2021
1Tachycardia (Tachyarrhythmias)
06/2021
1Necrosis
05/2021
1Body Weight (Weight, Body)
03/2021
1Hypertriglyceridemia
01/2019
1Hyperglycemia
01/2019
1Fibrosis (Cirrhosis)
01/2019
1Ischemic Stroke
12/2018

Drug/Important Bio-Agent (IBA)

5Anticonvulsants (Antiepileptic Drugs)IBA
02/2023 - 11/2006
4Capsaicin (Zostrix)FDA Link
05/2024 - 06/2015
4Formaldehyde (Formol)FDA Link
05/2024 - 06/2015
4LigandsIBA
11/2023 - 03/2021
4Prazosin (Minipress)FDA LinkGeneric
11/2023 - 01/2019
4MH-76 compoundIBA
11/2023 - 01/2019
4QuinazolinesIBA
11/2023 - 01/2019
3LipidsIBA
02/2024 - 05/2021
3Serotonin (5 Hydroxytryptamine)IBA
11/2023 - 03/2022
3Antihypertensive Agents (Antihypertensives)IBA
11/2023 - 01/2019
3FructoseIBA
11/2023 - 01/2019
3Analgesics (Analgesic Drugs)IBA
02/2023 - 06/2015
3Epinephrine (Adrenaline)FDA LinkGeneric
07/2014 - 02/2008
2Streptozocin (Streptozotocin)FDA Link
05/2024 - 11/2020
2Adrenergic Receptors (Adrenergic Receptor)IBA
11/2023 - 05/2021
2PiperazineIBA
11/2023 - 05/2021
2Histamine (Histamine Dihydrochloride)FDA Link
10/2023 - 06/2022
2LeptinIBA
06/2022 - 05/2021
2MH-79 compoundIBA
01/2019 - 01/2019
2ZymosanIBA
01/2017 - 06/2015
2CarrageenanIBA
01/2017 - 06/2015
1Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2024
1TriazinesIBA
11/2023
1Ether (Diethyl Ether)IBA
11/2023
1Adrenergic Antagonists (Antiadrenergic Agents)IBA
11/2023
1sigma Receptors (sigma Receptor)IBA
10/2023
1AntipruriticsIBA
10/2023
1XanthineIBA
08/2023
1ResistinIBA
06/2022
1Triglycerides (Triacylglycerol)IBA
06/2022
1Glucose (Dextrose)FDA LinkGeneric
06/2022
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
06/2022
1sigma-2 receptorIBA
06/2022
1Antipsychotic Agents (Antipsychotics)IBA
03/2022
1N-dodecyl-L-lysine amideIBA
03/2022
1cariprazineIBA
03/2022
1Amphetamine (Amfetamine)FDA LinkGeneric
03/2022
1Dopamine (Intropin)FDA LinkGeneric
03/2022
1Serotonin ReceptorsIBA
03/2022
1Neurotransmitter Agents (Neurotransmitter)IBA
03/2022
1Serotonin 5-HT2 Receptor AntagonistsIBA
01/2022
1azasteneIBA
01/2022
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
10/2021
1Tiagabine (Gabitril)FDA Link
06/2021
1Ion Channels (Ion Channel)IBA
06/2021
1Interleukin-6 (Interleukin 6)IBA
05/2021
1Doxazosin (Cardura)FDA LinkGeneric
05/2021
1Plasminogen Activator Inhibitor 1IBA
05/2021
1Insulin (Novolin)FDA Link
05/2021
1Drinking WaterIBA
01/2019
1SaltsIBA
01/2019
1Desoxycorticosterone Acetate (DOCA)FDA Link
01/2019
1Guanosine Monophosphate (5' Guanylic Acid)IBA
01/2019
1Desoxycorticosterone (Deoxycorticosterone)IBA
01/2019
1AntioxidantsIBA
01/2019
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2019
1Acetates (Acetic Acid Esters)FDA Link
01/2019
1Therapeutic UsesIBA
01/2019
1Clopidogrel (Plavix)FDA Link
12/2018
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2018

Therapy/Procedure

2Therapeutics
11/2023 - 05/2021
1Anesthesia
02/2023
1Local Anesthesia
02/2023
1Secondary Prevention
12/2018